Maximilian Diehn

Stanford University

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index89
i10-index198
Publications750
Citations57,533

Grants

40 total · 7 active

NIH #5R01CA290715-03

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$627K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

NIH #5R01CA290715-02

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$627K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

NIH #1R01CA290715-01

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$628K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

40 total · 7 active

NIH #5R01CA290715-03

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$627K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

NIH #5R01CA290715-02

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$627K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

NIH #1R01CA290715-01

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$628K
Period
2024-05-15 → 2029-04-30
PIs
2
Est. capacity / PI
~2 students

NIH #5P01CA257907-04

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

Active
Amount
$2.0M
Period
2022-09-21 → 2027-08-31
PIs
2
Est. capacity / PI
~3 students

NIH #5P01CA257907-03

Project 3: Targeting KEAP1-Mediated Radioresistance in Lung Cancer

Active
Amount
$347K
Period
2022-09-21 → 2027-08-31
PIs
1
Est. capacity / PI
~1 students

NIH #5P01CA257907-02

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

Active
Amount
$2.0M
Period
2022-09-21 → 2027-08-31
PIs
2
Est. capacity / PI
~3 students

NIH #1P01CA257907-01A1

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

Active
Amount
$2.1M
Period
2022-09-21 → 2027-08-31
PIs
2
Est. capacity / PI
~4 students

NIH #5R01CA244526-05

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$560K
Period
2020-07-01 → 2026-06-30
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA254179-05

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$598K
Period
2020-08-01 → 2026-04-30
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA257655-02

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$641K
Period
2021-03-04 → 2026-02-28
PIs
2
Est. capacity / PI
~0 students

NIH #1R01CA257655-01

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$655K
Period
2021-03-04 → 2026-02-28
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA257655-05

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$654K
Period
2021-03-04 → 2026-02-28
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA257655-04

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$621K
Period
2021-03-04 → 2026-02-28
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA257655-03

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$641K
Period
2021-03-04 → 2026-02-28
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA244526-04

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$585K
Period
2020-07-01 → 2025-06-30
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA244526-03

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$595K
Period
2020-07-01 → 2025-06-30
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA244526-02

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$618K
Period
2020-07-01 → 2025-06-30
PIs
3
Est. capacity / PI
~0 students

NIH #1R01CA244526-01A1

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$626K
Period
2020-07-01 → 2025-06-30
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA254179-04

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$617K
Period
2020-08-01 → 2025-04-30
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA254179-03

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$617K
Period
2020-08-01 → 2025-04-30
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA254179-02

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$632K
Period
2020-08-01 → 2025-04-30
PIs
2
Est. capacity / PI
~0 students

NIH #1R01CA254179-01

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$641K
Period
2020-08-01 → 2025-04-30
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA233578-05

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$538K
Period
2019-02-01 → 2024-12-31
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA233975-05

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$548K
Period
2019-08-01 → 2024-07-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA233975-04

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$551K
Period
2019-08-01 → 2024-07-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA233975-03

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$562K
Period
2019-08-01 → 2024-07-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA233975-02

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$562K
Period
2019-08-01 → 2024-07-31
PIs
2
Est. capacity / PI
~0 students

NIH #1R01CA233975-01A1

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$562K
Period
2019-08-01 → 2024-07-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA233578-04

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$538K
Period
2019-02-01 → 2024-01-31
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA233578-03

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$549K
Period
2019-02-01 → 2024-01-31
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA233578-02

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$549K
Period
2019-02-01 → 2024-01-31
PIs
3
Est. capacity / PI
~0 students

NIH #1R01CA233578-01

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$549K
Period
2019-02-01 → 2024-01-31
PIs
3
Est. capacity / PI
~0 students

NIH #5R01CA188298-05

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$356K
Period
2015-06-01 → 2021-05-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA188298-04

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$367K
Period
2015-06-01 → 2020-05-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA188298-03

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$367K
Period
2015-06-01 → 2020-05-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R01CA188298-02

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$373K
Period
2015-06-01 → 2020-05-31
PIs
2
Est. capacity / PI
~0 students

NIH #1R01CA188298-01A1

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$377K
Period
2015-06-01 → 2020-05-31
PIs
2
Est. capacity / PI
~0 students

NIH #5R44CA199142-03

Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens

Amount
$730K
Period
2015-08-17 → 2019-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at CELL DATA SCIENCES, INC.

NIH #2R44CA199142-02A1

Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens

Amount
$736K
Period
2015-08-17 → 2019-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at CELL DATA SCIENCES, INC.

NIH #1DP2CA186569-01

Developing a genomic approach for cancer screening

Amount
$2.4M
Period
2013-09-30 → 2018-06-30
PIs
1
Est. capacity / PI
~0 students

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 94
Open author page on OpenAlex →